AQST Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $4.55

Capitalizzazione di Mercato (MRQ) $571M

P/E (TTM) -7.0

EPS (TTM) $-0.65

Ricavi (TTM) $54M

ROE (TTM) 121.1%

Intervallo 52 sett. $3–$8

AQST Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$45M

2017-12-31 → 2025-12-31

EPS$-0.78

2020-12-31 → 2025-12-31

Flusso di cassa libero$-53M

2018-12-31 → 2025-12-31

Margine netto-144.6%

2018-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	AQST	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	-7.0media 5 anni ≈-6.7	≈-6.7	·	·
P/S (TTM)	10.6media 5 anni ≈6.1	≈6.1	2.7	Sopravvalutato
P/B (MRQ)	-10.1media 5 anni ≈-6.5	≈-6.5	·	·
Prezzo / FCF (TTM)	-12.4media 5 anni ≈-10.4	≈-10.4	·	·
Prezzo / Flusso di cassa (TTM)	-12.6media 5 anni ≈-11.2	≈-11.2	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	AQST	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-97.5%media 5 anni ≈-79.9%	≈-79.9%	-1.8%	Debole
EBITDA Margin (Margine EBITDA)	-159.5%media 5 anni ≈-79.9%	≈-79.9%	1.8%	Debole
Margine ante imposte (TTM)	-144.6%media 5 anni ≈-106.5%	≈-106.5%	-6.8%	Debole
Margine di Profitto Netto (TTM)	-144.6%media 5 anni ≈-106.6%	≈-106.6%	-7.5%	Debole
ROA (TTM)	-69.3%media 5 anni ≈-67.5%	≈-67.5%	-15.7%	Debole
ROE (TTM)	121.1%media 5 anni ≈79.2%	≈79.2%	52.3%	Di prim'ordine
ROIC	211.1%media 5 anni ≈70.9%	≈70.9%	40.3%	Di prim'ordine

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	AQST	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		7.2media 5 anni ≈2.6	≈2.6	3.0	Liquidità elevata
Quick Ratio		0.4	·	2.0	Liquidità elevata

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	AQST	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-22.6%media 5 anni ≈0.39%	≈0.39%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	-2.2%media 5 anni ≈1.8%	≈1.8%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	-0.58%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	AQST	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-0.78media 5 anni ≈$-0.88	≈$-0.88	·	·
Revenue / Share (Ricavi / Azione)	$0.42media 5 anni ≈$0.84	≈$0.84	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-0.49media 5 anni ≈$-0.41	≈$-0.41	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	AQST	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.3media 5 anni ≈0.7	≈0.7	0.5	Debole
Inventory Turnover (Rotazione delle scorte)	3.0media 5 anni ≈3.0	≈3.0	3.0	In linea
Receivables Turnover (Rotazione dei crediti)	3.5	·	3.5	Debole
Revenue / Employee (Ricavi / Dipendente)	≈$303.0K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 6.6%

Prossimo report Nov 03, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 11, 2026	$-0.08	$-0.11	24.1%
31 Marzo 2026	Mag 13, 2026	$-0.07	$-0.14	50.0%
31 Dicembre 2025		$-0.15	$-0.14	-10.9%
30 Settembre 2025		$-0.14	$-0.14	-3.6%
30 Giugno 2025		$-0.14	$-0.17	18.5%
31 Marzo 2025		$-0.24	$-0.17	-38.4%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 16

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$45M	$58M	$51M	$48M	$51M	$46M	$53M	$67M	$67M
Cost of Revenue	$19M	$18M	$21M	$19M	·	$13M	$20M	·	·
R&D Expense	$17M	$20M	$13M	$17M	$17M	$20M	$21M	$23M	$22M
SG&A Expense	$80M	$50M	$32M	$53M	$53M	$56M	$64M	$72M	$25M
Operating Expenses	$116M	$88M	$66M	$90M	$86M	$89M	$105M	$116M	$67M
Operating Income	$-71M	$-31M	$-15M	$-42M	$-35M	$-43M	$-53M	$-49M	$-113.0K
Interest Expense	·	·	$6M	$7M	$10M	$11M	$9M	$8M	$8M
Interest Income	·	·	·	·	·	$132.0K	$636.0K	·	·
Pretax Income	$-84M	$-44M	$-8M	$-54M	$-71M	$-56M	$-66M	$-61M	$-9M
Income Tax	$0	$-14.0K	$245.0K	$0	$0	$0	$0	$0	$0
Net Income	$-84M	$-44M	$-8M	$-54M	$-71M	$-56M	$-66M	$-61M	$-9M
EPS (Basic)	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85	$-1.66	·	·	·
EPS (Diluted)	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85	$-1.66	·	·	·
Shares (Basic)	106,926,528	86,726,211	61,255,864	48,734,377	38,077,660	33,651,127	·	·	·
Shares (Diluted)	106,926,528	86,726,211	61,255,864	48,734,377	38,077,660	33,651,127	·	·	·
EBITDA	$-71M	$-31M	$-15M	$-42M	$-35M	$-43M	$-53M	$-46M	·

Stato Patrimoniale 24

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$121M	$72M	$24M	$27M	$28M	$32M	$49M	$61M	$17M
Receivables	$18M	$7M	$8M	·	·	·	·	·	$6M
Inventory	$6M	$6M	$7M	$6M	$4M	$2M	$3M	$5M	$4M
Prepaid Expense	$4M	$3M	$2M	$2M	$3M	$3M	$3M	$2M	$591.0K
Current Assets	$149M	$88M	$41M	$40M	$47M	$45M	$68M	$74M	$28M
PP&E (Net)	$4M	$4M	$4M	$4M	$5M	$7M	$10M	$12M	$13M
PP&E (Gross)	$48M	$47M	$47M	$46M	$45M	$48M	$48M	$47M	$45M
Accum. Depreciation	$44M	$44M	$43M	$42M	$40M	$41M	$38M	$35M	$32M
Intangibles	$0	$0	$1M	$1M	$51.0K	$102.0K	$153.0K	$204.0K	$254.0K
Other Non-current Assets	$3M	$4M	$5M	$6M	$7M	$8M	$286.0K	$239.0K	$1M
Total Assets	$160M	$101M	$57M	$57M	$62M	$63M	$78M	$87M	$43M
Accounts Payable	$30M	$10M	$9M	$10M	$8M	$7M	$12M	$20M	$10M
Accrued Liabilities	$5M	$6M	$6M	$8M	$9M	$9M	$5M	$7M	$4M
Current Liabilities	$48M	$19M	$18M	$40M	$22M	$21M	$19M	$33M	$15M
Capital Leases	$4M	$5M	$5M	$5M	$2M	$3M	$0	·	·
Other Non-current Liabilities	$7M	$2M	$2M	$2M	$2M	$2M	$1M	·	·
Total Liabilities	$194M	$162M	$164M	$176M	$144M	$111M	$85M	$77M	$70M
Long-term Debt	$45M	$45M	$45M	·	·	$52M	$70M	·	·
Common Stock	$122.0K	$91.0K	$69.0K	$55.0K	$41.0K	$35.0K	$34.0K	$25.0K	$0
Paid-in Capital	$413M	$303M	$213M	$193M	$175M	$138M	$124M	$71M	$0
Retained Earnings	$-447M	$-363M	$-319M	$-311M	$-257M	$-186M	$-130M	$-61M	$-120M
Stockholders' Equity	$-34M	$-60M	$-106M	$-119M	$-82M	$-48M	$-6M	$10M	$-26M
Liabilities + Equity	$160M	$101M	$57M	$57M	$62M	$63M	$78M	$87M	$43M
Shares Outstanding	122,044,299	91,413,742	68,533,085	54,827,734	41,228,736	34,569,254	33,562,885	24,957,309	·

Flusso di cassa 13

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$548.0K	$718.0K	$1M	$2M	$3M	$3M	$3M	$3M	$4M
Stock-based Comp	$8M	$7M	$3M	$4M	$7M	$7M	$7M	$30M	$0
Deferred Tax	$0	$0	$0	$0	·	·	·	·	·
Amort. of Intangibles	$0	$78.0K	$157.0K	$116.0K	$51.0K	$51.0K	$50.0K	$50.0K	$51.0K
Other Non-cash	·	·	·	·	·	·	·	$15M	·
Operating Cash Flow	$-52M	$-36M	$-6M	$-10M	$-33M	$-45M	$-60M	$-13M	$6M
CapEx	$562.0K	$159.0K	$995.0K	$1M	$913.0K	$517.0K	$663.0K	$2M	$2M
Investing Cash Flow	$-562.0K	$-159.0K	$-995.0K	$-3M	$-913.0K	$-517.0K	$-663.0K	$-2M	$-2M
Financing Cash Flow	$103M	$84M	$4M	$12M	$30M	$28M	$50M	$58M	$4M
Net Change in Cash	$50M	$48M	$-3M	$-751.0K	$-4M	$-18M	·	$43M	$8M
Taxes Paid	$0	$305.0K	$0	·	·	·	·	·	·
Free Cash Flow	$-53M	$-36M	$-7M	$-11M	$-34M	$-46M	$-61M	$-15M	·
Levered FCF	·	·	$-14M	$-17M	$-44M	$-57M	$-70M	$-23M	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Operating Margin	-159.5%	-53.5%	-29.9%	-88.2%	-68.2%	-93.5%	-100.1%	-72.6%	·
Net Margin	-188.1%	-76.7%	-15.6%	-114.1%	-138.8%	-121.7%	-125.9%	-91.0%	·
Pretax Margin	-188.1%	-76.7%	-15.1%	-114.1%	-138.8%	-121.7%	-125.9%	-91.0%	·
EBITDA Margin	-159.5%	-53.5%	-29.9%	-88.2%	-68.2%	-93.5%	-100.1%	-67.8%	·
ROA	-64.0%	-55.6%	-13.8%	-91.4%	-113.0%	-78.9%	-80.1%	-94.5%	·
ROE	157.7%	83.6%	7.5%	48.1%	99.0%	131.2%	326.5%	-366.2%	·
ROIC	211.1%	51.1%	14.6%	35.5%	42.2%	88.4%	860.3%	-485.5%	·

Liquidità e Solvibilità 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	3.1	4.7	2.2	1.0	2.2	2.1	3.7	2.3	·
Quick Ratio	0.4	0.4	·	·	·	1.5	2.7	1.8	·
Interest Coverage	·	·	-2.4	-6.4	-3.5	-3.9	-5.7	-6.3	·

Efficienza 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.3	0.7	0.9	0.8	0.8	0.6	0.6	1.0	·
Inventory Turnover	3.0	2.8	3.3	·	·	4.9	·	·	·
Receivables Turnover	3.5	7.3	·	·	·	·	·	·	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$-0.28	$-0.66	$-1.55	$-2.16	$-1.99	$-1.40	$-0.18	$0.40	·
Revenue / Share	$0.42	$0.66	$0.83	$0.98	$1.33	·	·	·	·
Cash Flow / Share	$-0.49	$-0.41	$-0.10	$-0.20	$-0.87	·	·	·	·
Cash / Share	·	·	·	·	·	$0.92	$1.47	$2.43	·
EPS (TTM)	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85	$-1.66	·	·	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-22.6%	13.8%	6.1%	-6.2%	10.9%	·	·	·	·
Revenue CAGR 3Y	-2.2%	4.2%	3.3%	·	·	·	·	·	·
Revenue CAGR 5Y	-0.58%	·	·	·	·	·	·	·	·

Valutazione (TTM) 9

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$45M	$58M	$51M	$48M	$51M	$46M	$53M	$67M	·
Net Income TTM	$-84M	$-44M	$-8M	$-54M	$-71M	$-56M	$-66M	$-61M	·
Market Cap	$788M	$325M	$138M	$49M	$160M	$185M	$195M	$157M	·
P/E	-8.3	-7.0	-15.5	-0.8	-2.1	-3.2	·	·	·
P/S	17.7	5.7	2.7	1.0	3.2	4.0	3.7	2.3	·
P/B	-23.4	-5.4	-1.3	-0.4	-2.0	-3.8	-31.9	15.6	·
P / Cash Flow	-15.0	-9.1	-21.7	-5.1	-4.9	-4.1	-3.2	-12.1	·
P / FCF	-14.9	-9.1	-18.8	-4.6	-4.7	-4.0	-3.2	-10.6	·
Earnings Yield	-12.1%	-14.3%	-6.4%	-124.2%	-47.6%	-31.0%	·	·	·

Conto Economico 15

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$14M	$14M	$13M	$13M	$10M	$9M	$12M	$14M	$20M	$12M	$13M	$13M	$13M	$11M	$11M	$11M
Cost of Revenue	$4M	$3M	$6M	$5M	$5M	$4M	$5M	$4M	$5M	$4M	$5M	$5M	$7M	$5M	$5M	$5M
R&D Expense	$4M	$4M	$3M	$5M	$4M	$5M	$5M	$5M	$4M	$6M	$3M	$3M	$3M	$4M	$4M	$3M
SG&A Expense	$14M	$11M	$33M	$15M	$13M	$19M	$16M	$12M	$11M	$11M	$10M	$7M	$7M	$7M	$12M	$12M
Operating Expenses	$22M	$19M	$42M	$24M	$21M	$28M	$25M	$22M	$20M	$21M	$17M	$15M	$17M	$16M	$21M	$20M
Operating Income	$-8M	$-4M	$-29M	$-11M	$-11M	$-19M	$-14M	$-8M	$55.0K	$-9M	$-4M	$-2M	$-4M	$-5M	$-11M	$-9M
Interest Expense	·	·	·	·	·	·	·	·	$3M	$3M	·	$1M	$1M	$1M	$2M	$2M
Pretax Income	$-23M	$-8M	$-32M	$-15M	$-14M	$-23M	$-17M	$-12M	$-3M	$-13M	$-8M	$-2M	$-6M	$8M	$-12M	$-13M
Income Tax	$0	$0	$0	$0	$0	$0	$-14.0K	$0	$0	$0	$101.0K	$-140.0K	$284.0K	$0	$0	$0
Net Income	$-23M	$-8M	$-32M	$-15M	$-14M	$-23M	$-17M	$-12M	$-3M	$-13M	$-8M	$-2M	$-6M	$8M	$-12M	$-13M
EPS (Basic)	$-0.18	$-0.07	$-0.26	$-0.14	$-0.14	$-0.24	$-0.18	$-0.13	$-0.03	$-0.17	$-0.15	$-0.03	$-0.10	$0.15	$-0.21	$-0.23
EPS (Diluted)	$-0.18	$-0.07	$-0.26	$-0.14	$-0.14	$-0.24	$-0.18	$-0.13	$-0.03	$-0.17	$-0.11	$-0.03	$-0.10	$0.11	$-0.21	$-0.23
Shares (Basic)	124,994,165	122,609,995	·	110,584,371	99,326,701	95,497,056	·	91,082,081	90,911,626	73,614,710	·	64,678,761	57,350,902	55,631,947	·	53,424,922
Shares (Diluted)	124,994,165	122,609,995	·	110,584,371	99,326,701	95,497,056	·	91,082,081	90,911,626	73,614,710	·	64,678,761	57,350,902	73,792,886	·	53,424,922
EBITDA	$-8M	$-4M	·	$-11M	$-11M	$-19M	·	$-8M	$55.0K	$-9M	·	$-2M	$-4M	$-5M	·	$-9M

Stato Patrimoniale 24

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$98M	$111M	·	$129M	$61M	$69M	·	$78M	$90M	$95M	·	$25M	$22M	$27M	·	$19M
Receivables	$9M	$7M	$18M	·	·	·	$7M	·	·	·	$8M	·	·	·	·	·
Inventory	$7M	$8M	$6M	$8M	$8M	$7M	$6M	$7M	$7M	$8M	$7M	$7M	$6M	$7M	$6M	$7M
Prepaid Expense	$3M	$5M	$4M	$3M	$1M	$3M	$3M	$2M	$1M	$2M	$2M	$2M	$1M	$2M	$2M	$2M
Current Assets	$118M	$130M	$149M	$152M	$82M	$89M	$88M	$97M	$104M	$113M	$41M	$42M	$40M	$44M	$40M	$38M
PP&E (Net)	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$5M	$5M	$4M	$4M	$4M
PP&E (Gross)	$48M	$48M	$48M	$48M	$48M	$47M	$47M	$47M	$47M	$47M	$47M	$47M	$47M	$46M	$46M	$46M
Accum. Depreciation	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$43M	$43M	$43M	$43M	$43M	$42M	$42M	$42M	$42M
Intangibles	·	·	$0	$0	$0	$0	$0	$0	$0	$1M	$1M	$1M	$1M	$1M	$1M	$1M
Other Non-current Assets	$2M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$6M	$6M	$6M
Total Assets	$132M	$141M	$160M	$164M	$94M	$102M	$101M	$110M	$118M	$130M	$57M	$59M	$57M	$61M	$57M	$52M
Accounts Payable	$9M	$12M	$30M	$11M	$12M	$12M	$10M	$8M	$6M	$11M	$9M	$10M	$11M	$12M	$10M	$11M
Accrued Liabilities	$5M	$3M	$5M	$5M	$5M	$3M	$6M	$5M	$6M	$5M	$6M	$5M	$4M	$5M	$8M	$8M
Current Liabilities	$16M	$32M	$48M	$26M	$23M	$18M	$19M	$15M	$14M	$18M	$18M	$24M	$39M	$40M	$40M	$37M
Capital Leases	$8M	$4M	$4M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$6M	$6M	$6M	$5M	$1M
Other Non-current Liabilities	$6M	$6M	$7M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Total Liabilities	$189M	$175M	$194M	$168M	$166M	$163M	$162M	$155M	$153M	$166M	$164M	$162M	$164M	$171M	$176M	$160M
Long-term Debt	$55M	$45M	$45M	$45M	$45M	$45M	·	$45M	$45M	$45M	·	$39M	$39M	$42M	·	$52M
Common Stock	$126.0K	$124.0K	$122.0K	$121.0K	$99.0K	$99.0K	$91.0K	$91.0K	$91.0K	$90.0K	$69.0K	$67.0K	$62.0K	$56.0K	$55.0K	$54.0K
Paid-in Capital	$421M	$421M	$413M	$411M	$327M	$325M	$303M	$301M	$299M	$296M	$213M	$208M	$202M	$194M	$193M	$191M
Retained Earnings	$-478M	$-455M	$-447M	$-415M	$-400M	$-386M	$-363M	$-346M	$-335M	$-332M	$-319M	$-311M	$-309M	$-303M	$-311M	$-299M
Stockholders' Equity	$-57M	$-34M	$-34M	$-4M	$-73M	$-61M	$-60M	$-45M	$-35M	$-36M	$-106M	$-103M	$-107M	$-109M	$-119M	$-108M
Liabilities + Equity	$132M	$141M	$160M	$164M	$94M	$102M	$101M	$110M	$118M	$130M	$57M	$59M	$57M	$61M	$57M	$52M
Shares Outstanding	125,511,648	124,284,542	122,044,299	121,658,113	99,353,270	99,317,153	91,413,742	91,178,193	91,059,760	90,478,731	68,533,085	66,740,765	61,615,959	55,922,361	54,827,734	53,852,126

Flusso di cassa 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$136.0K	$113.0K	$130.0K	$139.0K	$140.0K	$139.0K	$147.0K	$159.0K	$205.0K	$207.0K	$467.0K	$264.0K	$289.0K	$325.0K	$397.0K	$596.0K
Stock-based Comp	$3M	$2M	$1M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$940.0K	$774.0K	$631.0K	$344.0K	$714.0K	$535.0K
Amort. of Intangibles	·	·	$0	$0	$0	$0	$0	$0	$39.0K	$39.0K	$40.0K	$39.0K	$39.0K	$39.0K	$51.0K	$39.0K
Operating Cash Flow	$-9M	$-15M	$-8M	$-13M	$-8M	$-23M	$-6M	$-12M	$-7M	$-10M	$-5M	$-2M	$-8M	$9M	$8M	$3M
CapEx	$212.0K	$52.0K	$85.0K	$235.0K	$107.0K	$135.0K	$15.0K	$80.0K	$35.0K	$29.0K	$16.0K	$151.0K	$826.0K	$2.0K	$26.0K	$217.0K
Investing Cash Flow	$-212.0K	$-52.0K	$-85.0K	$-235.0K	$-107.0K	$-135.0K	$-15.0K	$-80.0K	$-35.0K	$-29.0K	$-16.0K	$-151.0K	$-826.0K	$-2.0K	$-26.0K	$-2M
Financing Cash Flow	$-3M	$4M	$660.0K	$81M	$-100.0K	$21M	$157.0K	$-17.0K	$2M	$82M	$4M	$5M	$4M	$-9M	$234.0K	$-138.0K
Net Change in Cash	$-12M	$-10M	$-8M	$69M	$-8M	$-3M	$-6M	$-12M	$-5M	$71M	$-1M	$2M	$-4M	$-391.0K	$9M	$954.0K
Taxes Paid	·	·	$0	$0	$-2M	$2M	$0	$0	$-698.0K	$1M	$0	$0	·	·	·	·
Free Cash Flow	·	$-15M	·	·	·	$-24M	·	·	·	$-10M	·	·	·	$9M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-13M	·	·	·	$7M	·	·

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-59.5%	-29.1%	·	-89.6%	-113.7%	-222.1%	·	-61.2%	0.27%	-74.3%	·	-18.3%	-31.8%	-41.4%	·	-77.2%
Net Margin	-165.5%	-55.8%	·	-120.6%	-135.4%	-263.0%	·	-85.0%	-13.7%	-106.4%	·	-15.7%	-43.7%	72.5%	·	-109.4%
Pretax Margin	-165.5%	-55.8%	·	-120.6%	-135.4%	-263.0%	·	-85.0%	-13.7%	-106.4%	·	-16.7%	-41.6%	72.5%	·	-109.4%
EBITDA Margin	-59.5%	-29.1%	·	-89.6%	-113.7%	-222.1%	·	-61.2%	0.27%	-74.3%	·	-18.3%	-31.8%	-41.4%	·	-77.2%
ROA	-20.2%	-6.6%	·	-11.3%	-12.8%	-19.8%	·	-13.6%	-3.1%	-13.5%	·	-3.7%	-10.2%	13.7%	·	-21.4%
ROE	35.4%	17.0%	·	62.4%	25.1%	47.2%	·	15.5%	3.9%	17.6%	·	1.9%	5.7%	-8.0%	·	14.9%
ROIC	14.5%	12.3%	·	279.4%	15.7%	31.8%	·	18.2%	-0.16%	24.7%	·	2.2%	4.2%	4.2%	·	8.2%

Liquidità e Solvibilità 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	7.2	4.1	·	5.9	3.5	4.9	·	6.4	7.5	6.3	·	1.8	1.0	1.1	·	1.0
Quick Ratio	6.5	3.7	·	5.0	2.6	3.8	·	5.1	6.5	5.3	·	1.0	0.6	0.7	·	0.5
Interest Coverage	·	·	·	·	·	·	·	·	0.0	-3.2	·	-1.9	-3.1	-3.2	·	-5.4

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.2	0.2	0.1	·	0.2	0.2	0.2	·	0.2
Inventory Turnover	0.5	0.5	·	0.6	0.6	0.5	·	0.6	0.7	0.6	·	0.7	1.2	0.8	·	1.0
Receivables Turnover	1.7	4.2	·	·	·	·	·	·	·	·	·	·	·	·	·	·

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$-0.45	$-0.27	·	$-0.03	$-0.73	$-0.61	·	$-0.50	$-0.39	$-0.40	·	$-1.54	$-1.73	$-1.95	·	$-2.00
Revenue / Share	$0.11	$0.12	·	$0.12	$0.10	$0.09	·	$0.15	$0.22	$0.16	·	$0.20	$0.23	$0.15	·	$0.21
Cash Flow / Share	·	$-0.12	·	·	·	$-0.24	·	·	·	$-0.14	·	·	·	$0.12	·	·
Cash / Share	$0.78	$0.89	·	$1.06	$0.61	$0.69	·	$0.85	$0.99	$1.05	·	$0.37	$0.36	$0.48	·	$0.35
EPS (TTM)	$-0.65	$-0.61	·	$-0.70	$-0.69	$-0.58	·	$-0.44	$-0.34	$-0.41	·	$-0.23	$-0.43	$-0.69	·	$-1.65

Valutazione (TTM) 8

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$54M	$50M	·	$43M	$44M	$54M	·	$59M	$58M	$52M	·	$48M	$47M	$47M	·	$48M
Net Income TTM	$-78M	$-69M	·	$-69M	$-65M	$-54M	·	$-35M	$-26M	$-29M	·	$-12M	$-23M	$-33M	·	$-71M
Market Cap	$522M	$516M	·	$680M	$329M	$288M	·	$454M	$237M	$385M	·	$102M	$102M	$64M	·	$63M
P/E	-6.4	-6.8	·	-8.0	-4.8	-5.0	·	-11.3	-7.6	-10.4	·	-6.7	-3.8	-1.7	·	-0.7
P/S	9.7	10.3	·	15.7	7.5	5.3	·	7.7	4.1	7.5	·	2.1	2.2	1.4	·	1.3
P/B	-9.2	-15.1	·	-165.5	-4.5	-4.7	·	-10.0	-6.7	-10.6	·	-1.0	-1.0	-0.6	·	-0.6
P / Cash Flow	·	-34.8	·	·	·	-12.3	·	·	·	-37.1	·	·	·	7.2	·	·
Earnings Yield	-15.6%	-14.7%	·	-12.5%	-20.8%	-20.0%	·	-8.8%	-13.1%	-9.6%	·	-15.0%	-26.1%	-60.5%	·	-141.0%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$45M	$58M	$51M	$48M	$51M
Margine Operativo %	-159.5%	-53.5%	-29.9%	-88.2%	-68.2%
Utile netto	$-84M	$-44M	$-8M	$-54M	$-71M
EPS Diluito	$-0.78	$-0.51	$-0.13	$-1.12	$-1.85

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	3.1	4.7	2.2	1.0	2.2
Quick Ratio	0.4	0.4	·	·	·

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-53M	$-36M	$-7M	$-11M	$-34M

Proprietari istituzionali (13F) 196 filer · $337.8M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 196

Valore detenuto $337.8M

Nuove posizioni 26

Posizioni chiuse 18

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
26 (-23 vs trimestre precedente)	18 (-29 vs trimestre precedente)	68 (+9 vs trimestre precedente)	49 (0 vs trimestre precedente)	-1.2M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
Bratton Capital Management, L.P.	$40.813.585	9.810.958	12,08%	Azioni
VANGUARD GROUP INC	$38.064.478	5.892.334	11,27%	Azioni
BlackRock, Inc.	$33.568.590	8.069.373	9,94%	Azioni
RTW INVESTMENTS, LP	$30.894.119	7.426.471	9,15%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$19.071.657	4.584.533	5,65%	Azioni
FEDERATED HERMES, INC.	$12.948.253	3.112.561	3,83%	Azioni
STATE STREET CORP	$12.180.563	2.928.020	3,61%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$10.913.743	2.622.888	3,23%	Azioni
SAMSARA BIOCAPITAL, LLC	$10.400.000	2.500.000	3,08%	Azioni
BANK OF AMERICA CORP /DE/	$6.940.640	1.668.423	2,05%	Azioni
Sio Capital Management, LLC	$6.182.488	1.486.175	1,83%	Azioni
Propel Bio Management, LLC	$6.000.372	1.442.397	1,78%	Azioni
TWO SIGMA INVESTMENTS, LP	$5.329.904	1.281.227	1,58%	Azioni
Nuveen, LLC	$5.055.336	1.215.225	1,50%	Azioni
WELLS FARGO & COMPANY/MN	$4.530.394	1.089.037	1,34%	Azioni
COMMONWEALTH EQUITY SERVICES, LLC	$4.352.090	1.046.175	1,29%	Azioni
BARCLAYS PLC	$4.146.126	996.665	1,23%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$3.951.168	949.800	1,17%	Opzione Call
Blue Owl Capital Holdings LP	$3.922.597	942.932	1,16%	Azioni
WASATCH ADVISORS LP	$3.645.011	878.316	1,08%	Azioni
NORTHERN TRUST CORP	$3.457.589	831.151	1,02%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$3.305.902	794.688	0,98%	Azioni
Balyasny Asset Management L.P.	$3.097.270	744.536	0,92%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.054.459	734.245	0,90%	Azioni
MORGAN STANLEY	$2.739.848	658.617	0,81%	Azioni
VANGUARD FIDUCIARY TRUST CO	$2.709.038	651.211	0,80%	Azioni
DAFNA Capital Management LLC	$2.687.006	645.915	0,80%	Azioni
Everstar Asset Management, LLC	$2.545.683	611.943	0,75%	Azioni
TWO SIGMA ADVISERS, LP	$2.147.304	332.400	0,64%	Azioni
AWM Investment Company, Inc.	$1.977.664	475.400	0,59%	Azioni
GOLDMAN SACHS GROUP INC	$1.949.247	468.569	0,58%	Azioni
Bracebridge Capital, LLC	$1.910.339	459.216	0,57%	Azioni
UBS Group AG	$1.907.002	458.414	0,56%	Azioni
CITADEL ADVISORS LLC	$1.881.140	452.197	0,56%	Azioni
JANE STREET GROUP, LLC	$1.819.958	437.490	0,54%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$1.731.592	416.248	0,51%	Azioni
STIFEL FINANCIAL CORP	$1.505.516	361.903	0,45%	Azioni
Man Group plc	$1.463.072	351.700	0,43%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.286.272	309.200	0,38%	Opzione Put
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.274.599	306.394	0,38%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$1.254.852	301.647	0,37%	Azioni
MARSHALL WACE, LLP	$1.188.340	285.659	0,35%	Azioni
Walleye Capital LLC	$1.175.483	282.568	0,35%	Azioni
Simplify Asset Management Inc.	$1.159.488	278.723	0,34%	Azioni
Bank of New York Mellon Corp	$1.146.264	275.544	0,34%	Azioni
Russell Investments Group, Ltd.	$1.083.599	260.481	0,32%	Azioni
Rosalind Advisors, Inc.	$1.040.000	250.000	0,31%	Azioni
Latash Investments, LLC	$1.011.437	243.134	0,30%	Azioni
Hudson Bay Capital Management LP	$973.440	234.000	0,29%	Azioni
Lido Advisors, LLC	$895.715	215.316	0,27%	Azioni

Mostra tutti i 196 proprietari istituzionali →

Insider aziendali 29 insider · 19 dirigenti · 11 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Daniel Barber	President and CEO	15 Settembre 2026 S	652.317	7	$-1.220.735
Keith J Kendall	CEO and President	10 Marzo 2022 A	1.000	0	$0
Ernest A Toth JR	Chief Financial Officer	05 Maggio 2026 F	283.460	1	$-242.919
John T. Maxwell	SVP-Chief Financial Officer	18 Agosto 2020 S	150.614	0	$0
Cassie Jung	Chief Operating Officer	03 Settembre 2026 X	206.833	2	$-664.649
Sherry Korczynski	Chief Commercial Officer	09 Settembre 2026 M	235.689	2	$-111.315
Peter E. Boyd	Chief People Officer	09 Settembre 2026 X	284.024	2	$-194.324
Thomas A. Zalewski	Chief Legal Officer	18 Maggio 2026 A	100.000	0	$0
Melina Cioffi	SVP, Regulatory Affairs	15 Maggio 2026 F	273.200	1	$-105.547
Lori J Braender	Corporate Secretary	07 Maggio 2026 F	231.042	1	$-167.225
Matthew J. Greenhawt	Chief Medical Officer	09 Marzo 2026 A	75.000	0	$0
Matthew W. Davis	Chief Development Officer	09 Marzo 2026 A	100.000	0	$0
Carl N Kraus	Chief Medical Officer	15 Ottobre 2025 S	282.475	1	$-141.904
Stephen Wargacki	Chief Science Officer	07 Marzo 2025 A	343.552	0	$0
Alexander Mark Schobel	Chief Innovation/Tech Officer	09 Marzo 2024 F	980.726	0	$0
Ken W. Marshall	SVP, Chief Commercial Officer	09 Agosto 2023 A	150.000	0	$0
Kenneth Truitt	Chief Medical Officer	06 Settembre 2022 A	·	0	$0
Theresa Wood	SVP-HR and Org. Development	10 Marzo 2022 A	80.765	0	$0
Gary H Slatko	SVP, Chief Medical Officer	16 Marzo 2020 A	·	0	$0
Julie Krop	Direttore	23 Giugno 2026 M	0	1	$-125.500
Abigail L. Jenkins	Direttore	10 Giugno 2026 A	·	0	$0
Marco Taglietti	Direttore	10 Giugno 2026 A	·	0	$0
John Cochran	Direttore	10 Giugno 2026 A	99.486	0	$0
Gregory B Brown	Direttore	10 Giugno 2026 A	·	0	$0
Timothy E Morris	Direttore	10 Giugno 2026 A	·	0	$0
COSTA SANTO J	Direttore	20 Giugno 2024 A	·	0	$0
Nancy Lurker	Direttore	15 Giugno 2021 A	·	0	$0
James S Scibetta	Direttore	15 Giugno 2021 A	31.635	0	$0
Douglas K Bratton	Proprietario del 10%	02 Dicembre 2024 G	199.841	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 16 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
PILL · Direxion Shares ETF Trust	0,51%	28.299 NS	31 Luglio 2026	N-PORT
QQQS · Invesco Exchange-Traded Fund Trust …	0,45%	23.471 SH	02 Ottobre 2026	Giornaliero
IWC · iShares Trust	0,13%	367.240 SH	11 Settembre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,04%	8.980 SH	02 Ottobre 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,02%	59.348 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,02%	2.767.037 SH	11 Settembre 2026	Giornaliero
IWO · iShares Trust	0,01%	374.338 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,01%	51.582 NS	31 Luglio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	621.390 SH	19 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,01%	43.284 SH	19 Agosto 2026	Giornaliero
ITOT · iShares Trust	0,00%	165.523 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,00%	34.314 SH	11 Settembre 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,00%	1.077.349 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	3.403.709 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	10.223 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	638.760 SH	11 Settembre 2026	Giornaliero

AQST Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 15 analisti COMPRA

Target mediano $10.00 +119,8%

4 26,7% Acquisto forte

10 66,7% Compra

1 6,7% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

9 analisti · 2026-10-04

Target medio $9.33 +105,1%

← Sotto tutti i target Prezzo attuale $4.55

Basso$6.00 Media$9.33 Alto$11.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
AQST	$788M	-8.3	-22.6%	-188.1%	157.7%	·
COLL	$1.47B	26.8	23.6%	8.1%	23.5%	59.4%
ACRS	$363M	-5.7	-58.2%	-829.6%	-55.3%	·
CRMD	$922M	5.7	617.0%	52.3%	52.1%	88.5%
ZVRA	$509M	6.6	350.9%	78.2%	61.2%	·
PHAT	$1.18B	-5.5	216.9%	-126.4%	52.4%	87.1%
EOLS	$432M	-8.3	11.6%	-17.4%	247.3%	66.3%
CTNM	·	-5.3	·	·	-27.7%	·
ARVN	$753M	-10.4	-0.30%	-30.8%	-15.5%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

AQST Aquestive Therapeutics, Inc. - Common Stock